Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2

Precision medicine is a rapidly-developing modality of medicine in human healthcare. Based on each patient׳s unique characteristics, more accurate dosages and drug selection can be made to achieve better therapeutic efficacy and less adverse reactions in precision medicine. A patient׳s individual pa...

Full description

Bibliographic Details
Main Authors: Liming Chen, Jose E. Manautou, Theodore P. Rasmussen, Xiao-bo Zhong
Format: Article
Language:English
Published: Elsevier 2019-07-01
Series:Acta Pharmaceutica Sinica B
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383518309158
_version_ 1818943330787000320
author Liming Chen
Jose E. Manautou
Theodore P. Rasmussen
Xiao-bo Zhong
author_facet Liming Chen
Jose E. Manautou
Theodore P. Rasmussen
Xiao-bo Zhong
author_sort Liming Chen
collection DOAJ
description Precision medicine is a rapidly-developing modality of medicine in human healthcare. Based on each patient׳s unique characteristics, more accurate dosages and drug selection can be made to achieve better therapeutic efficacy and less adverse reactions in precision medicine. A patient׳s individual parameters that affect drug transporter action can be used to develop a precision medicine guidance, due to the fact that therapeutic efficacy and adverse reactions of drugs can both be affected by expression and function of drug transporters on the cell membrane surface. The purpose of this review is to summarize unique characteristics of human breast cancer resistant protein (BCRP) and the genetic variability in the BCRP encoded gene ABCG2 in the development of precision medicine. Inter-individual variability of BCRP/ABCG2 can impact choices and outcomes of drug treatment for several diseases, including cancer chemotherapy. Several factors have been implicated in expression and function of BCRP, including genetic, epigenetic, physiologic, pathologic, and environmental factors. Understanding the roles of these factors in controlling expression and function of BCRP is critical for the development of precision medicine based on BCRP-mediated drug transport. Keywords: BCRP, Epigenetics, Gene polymorphisms, Physiologic factors, Precision medicine
first_indexed 2024-12-20T07:25:37Z
format Article
id doaj.art-8ed9d8c408e441bbb1b778bf67a2bcf7
institution Directory Open Access Journal
issn 2211-3835
language English
last_indexed 2024-12-20T07:25:37Z
publishDate 2019-07-01
publisher Elsevier
record_format Article
series Acta Pharmaceutica Sinica B
spelling doaj.art-8ed9d8c408e441bbb1b778bf67a2bcf72022-12-21T19:48:33ZengElsevierActa Pharmaceutica Sinica B2211-38352019-07-0194659674Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2Liming Chen0Jose E. Manautou1Theodore P. Rasmussen2Xiao-bo Zhong3Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USADepartment of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USACorresponding author. Tel.: +1 860 4863697.; Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USAPrecision medicine is a rapidly-developing modality of medicine in human healthcare. Based on each patient׳s unique characteristics, more accurate dosages and drug selection can be made to achieve better therapeutic efficacy and less adverse reactions in precision medicine. A patient׳s individual parameters that affect drug transporter action can be used to develop a precision medicine guidance, due to the fact that therapeutic efficacy and adverse reactions of drugs can both be affected by expression and function of drug transporters on the cell membrane surface. The purpose of this review is to summarize unique characteristics of human breast cancer resistant protein (BCRP) and the genetic variability in the BCRP encoded gene ABCG2 in the development of precision medicine. Inter-individual variability of BCRP/ABCG2 can impact choices and outcomes of drug treatment for several diseases, including cancer chemotherapy. Several factors have been implicated in expression and function of BCRP, including genetic, epigenetic, physiologic, pathologic, and environmental factors. Understanding the roles of these factors in controlling expression and function of BCRP is critical for the development of precision medicine based on BCRP-mediated drug transport. Keywords: BCRP, Epigenetics, Gene polymorphisms, Physiologic factors, Precision medicinehttp://www.sciencedirect.com/science/article/pii/S2211383518309158
spellingShingle Liming Chen
Jose E. Manautou
Theodore P. Rasmussen
Xiao-bo Zhong
Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
Acta Pharmaceutica Sinica B
title Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
title_full Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
title_fullStr Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
title_full_unstemmed Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
title_short Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
title_sort development of precision medicine approaches based on inter individual variability of bcrp abcg2
url http://www.sciencedirect.com/science/article/pii/S2211383518309158
work_keys_str_mv AT limingchen developmentofprecisionmedicineapproachesbasedoninterindividualvariabilityofbcrpabcg2
AT joseemanautou developmentofprecisionmedicineapproachesbasedoninterindividualvariabilityofbcrpabcg2
AT theodoreprasmussen developmentofprecisionmedicineapproachesbasedoninterindividualvariabilityofbcrpabcg2
AT xiaobozhong developmentofprecisionmedicineapproachesbasedoninterindividualvariabilityofbcrpabcg2